Back

The purine pathway in liver tissue biopsies from donors for transplantation is associated to immediate graft function and survival

Xu, J.; Hassan-Ally, M.; Casas-Ferreira, A. M.; Suvitaival, T.; Ma, Y.; Vilca-Melendez, H.; Rela, M.; Heaton, N.; Jassem, W.; Legido-Quigley, C.

2019-09-09 transplantation
10.1101/19005629
Show abstract

Background & AimsThe current shortage of livers for transplantation has increased the use of organs sourced from donation after circulatory death (DCD). These organs are prone to higher incidence of graft failure, but the underlying mechanisms are largely unknown. Here we aimed to find biomarkers of liver function before transplantation to better inform clinical evaluation. MethodsMatched pre- and post-transplant liver biopsies from DCD (n=24) and donation after brain death (DBD, n=70) were collected. Liver biopsies were analysed using mass spectroscopy molecular phenotyping. First, a discrimination analysis DCD vs DBD was used to parse metabolites associated to DCD. Then a data-driven approach was used to predict Immediate Graft Function (IGF). The metabolites were tested in models to predict survival. ResultsFive metabolites in the purine pathway were selected and investigated. The ratios of: adenine monophosphate (AMP), adenine, adenosine and hypoxanthine to urate, differed between DBD and DCD biopsies at pre-transplantation stage (q<0.05). The ratios of AMP and adenine to urate also differed in biopsies from recipients undergoing IGF (q<0.05). Using random forest a panel composed by alanine aminotransferase (ALT) and AMP, adenine, hypoxanthine ratio to urate predicted IGF with AUC 0.84 (95% CI [0.71, 0.97]). In comparison AUC 0.71 (95%CI [0.52, 0.90]) was achieved by clinical measures. Survival analysis revealed that the metabolite classifier could stratify 6-year survival outcomes (p = 0.0073) while clinical data and donor class could not. ConclusionsAt liver pre-transplantation stage, a panel composed of purine metabolites and ALT in tissue could improve prediction of IGF and survival. Lay summaryNew liver function biomarkers could help clinicians assess livers before transplantation. Purines are small molecules that are found in healthy livers, and in this work we found that their levels changed critically in livers from cardiac death donors. Measuring them before transplantation improved the prediction of the livers immediate graft function. Graphic abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=65 SRC="FIGDIR/small/19005629v1_ufig1.gif" ALT="Figure 1"> View larger version (16K): org.highwire.dtl.DTLVardef@1e3c207org.highwire.dtl.DTLVardef@1d760b0org.highwire.dtl.DTLVardef@10cf605org.highwire.dtl.DTLVardef@1ebebd5_HPS_FORMAT_FIGEXP M_FIG C_FIG HighlightsO_LIThe ratios of purine metabolites to urate differ between DCD and DBD in liver tissue at pre-transplantation. C_LIO_LIThe ratios of purine metabolites to urate and ALT pre-transplantation can improve prediction of IGF after transplantation. C_LIO_LIPurine metabolites ratios to urate stratified 6-year survival outcome better than clinical data and donor class. C_LI

Matching journals

1
Transplantation
Ovid Technologies (Wolters Kluwer Health) · based on 11 published papers
#1
385× avg
2
Scientific Reports
Springer Science and Business Media LLC · based on 701 published papers
Top 3%
3.3× avg
3
Advanced Science
Wiley · based on 12 published papers
#1
128× avg
4
Journal of Clinical Medicine
MDPI AG · based on 77 published papers
Top 2%
8.6× avg
5
Kidney360
Ovid Technologies (Wolters Kluwer Health) · based on 14 published papers
Top 0.7%
47× avg
6
American Journal of Transplantation
Elsevier BV · based on 13 published papers
Top 0.3%
90× avg
7
eLife
eLife Sciences Publications, Ltd · based on 262 published papers
Top 6%
3.1× avg
8
Frontiers in Immunology
Frontiers Media SA · based on 140 published papers
Top 2%
9.2× avg
9
Frontiers in Medicine
Frontiers Media SA · based on 99 published papers
Top 7%
3.9× avg
10
PLOS ONE
Public Library of Science (PLoS) · based on 1737 published papers
Top 82%
2.6%
11
Cell Reports Medicine
Elsevier BV · based on 49 published papers
Top 2%
13× avg
12
iScience
Elsevier BV · based on 74 published papers
Top 2%
7.8× avg
13
Science Translational Medicine
American Association for the Advancement of Science (AAAS) · based on 40 published papers
Top 2%
9.4× avg
14
Biomedicines
MDPI AG · based on 21 published papers
Top 2%
11× avg
15
Kidney International
Elsevier BV · based on 11 published papers
Top 0.9%
22× avg
16
Journal of the American Society of Nephrology
Ovid Technologies (Wolters Kluwer Health) · based on 19 published papers
Top 1%
16× avg
17
BMJ Open
BMJ · based on 553 published papers
Top 48%
0.9%
18
International Journal of Molecular Sciences
MDPI AG · based on 39 published papers
Top 3%
6.2× avg
19
American Journal of Respiratory and Critical Care Medicine
American Thoracic Society · based on 23 published papers
Top 2%
7.2× avg
20
Journal of Clinical Investigation
American Society for Clinical Investigation · based on 50 published papers
Top 4%
4.6× avg
21
Blood
American Society of Hematology · based on 14 published papers
Top 1%
10.0× avg
22
BMC Medicine
Springer Science and Business Media LLC · based on 155 published papers
Top 23%
0.7%